Gyre Therapeutics, Inc. (GYRE)
7.12
-0.11
(-1.52%)
USD |
NASDAQ |
Apr 02, 16:00
7.14
+0.02
(+0.28%)
After-Hours: 20:00
Gyre Therapeutics Market Cap : 642.06M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neogen Corp. | 2.052B |
| Zoetis, Inc. | 50.05B |
| Marker Therapeutics, Inc. | 21.67M |
| Savara, Inc. | 1.133B |
| Pulmatrix, Inc. | 4.676M |
Market Cap Related Metrics
| PE Ratio | 316.44 |
| PS Ratio | 6.104 |
| Price to Book Value | 6.132 |
| Price | 7.12 |
| Earnings Yield | 0.32% |
| Operating PE Ratio | 61.93 |
| Normalized PE Ratio | 1873.68 |